SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-06-002365
Filing Date
2006-02-28
Accepted
2006-02-28 15:53:12
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y17762e10vk.htm 10-K 1244364
2 EX-10.13.3: AMENDMENT NO. 3 TO COLLABORATION AGREEMENT y17762exv10w13w3.txt EX-10.13.3 24960
3 EX-10.13.4: AMENDMENT NO. 4 TO COLLABORATION AGREEMENT y17762exv10w13w4.txt EX-10.13.4 9559
4 EX-12.1: STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED CHARGE y17762exv12w1.txt EX-12.1 3738
5 EX-23.1: CONSENT OF PRICEWATERHOUSECOOPERS LLP y17762exv23w1.txt EX-23.1 924
6 EX-31.1: CERTIFICATION y17762exv31w1.txt EX-31.1 4742
7 EX-31.2: CERTIFICATION y17762exv31w2.txt EX-31.2 4820
8 EX-32: CERTIFICATION y17762exv32.txt EX-32 1562
  Complete submission text file 0000950123-06-002365.txt   1295983
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19034 | Film No.: 06650932
SIC: 2834 Pharmaceutical Preparations